BEL develops, manufactures and distributes disposable medical devices for urology, urodynamics, heart surgery and haemodialysis.

The transaction relates to BEL’s manufacturing activities of cardiac surgery cannulae, which the company was producing on an exclusive basis for Sorin. These cannulae are an integral part of Sorin cannulae offering and generated revenues of around €4m in 2013.

After the acquisitions of the Estech minimally invasive cannulae product line in 2011 and the CalMed product line in 2012, this acquisition represents a further step in Sorin’s strategy of strengthening its global position in this market segment.

Sorin Cardiac Surgery business unit president Michel Darnaud said: "This deal confirms Sorin Group’s commitment to further strengthen our presence in the cannulae segment and consolidate our relationship with cardiac surgeons and clinical perfusionists worldwide."